Skip to main content
Figure 9 | Reproductive Biology and Endocrinology

Figure 9

From: Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs)

Figure 9

Representative endometrial biopsies of subjects treated with asoprisnil for 28 days. The photographs show examples consistent with the diagnosis "non-physiologic secretory effect". a: Weakly secretory glands with vacuoles below nuclei (solid arrow; Subject MN-6; asoprisnil 10 mg QD); b: Thick-walled vessels (open arrow; Subject MN-6; asoprisnil 10 mg); c: Mild to moderate secretory glands at low magnitude. Note area of relatively dense stroma. (subject MN, 25 mg BID); d: Moderate secretory glands with subnuclear vacuoles at higher magnitude (solid arrow; subject MN, 25 mg BID). QD, once a day. BID, twice a day. From [10] with permission.

Back to article page

Reproductive Biology and Endocrinology

ISSN: 1477-7827

Contact us